Health and Human Service's Office of Inspector General issued an advisory opinion in December of 2017 indicating that Pharma support of a program to conduct MTM post discharge would not violate anti-kickback rules. The permission was outlined in an advisory…
A post marketing requirement (PMR) is a study or clinical trial that a pharmaceutical company is required by statute or regulation to conduct post approval of a drug product. On December 8, 2017 the FDA released it’s annual report summarizing…
MEDICARE PROPOSALS On November 28th, the Centers for Medicare and Medicaid Services (CMS) published “Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the…
Have you ever heard the joke about the guy caught in a flood. To escape the flood he climbs up onto his roof. As the water continues to rise a man on a makeshift raft passes and offers him a…
CSS is excited to announce that we have just launched our Continuity of Care Document (CCD) Integration. CCD Integration moves CSS and MTMPathTM significantly along the interoperability path. With the new CCD Integration functionality, medication and care management clinicians using the…
Manufacturers of biologic drugs over the past few years have been “pulling out all the stops” to make it difficult for less expensive biosimilar products to come to market. Biologic drug manufactures have used tactics like patent infringement suits to…
CSS has put together a list of key points and associated feedback that we gained from: Attending the CMS Spring Conference’s MTM Pilot Audit panel discussion Our direct experience with our first CMS MTM Pilot/Program Audit. 2017 CMS Spring Conference…
From April 5-9th, 2017 the Elevate Pharmacy Virtual Summit will present the industry’s first ever completely web-based pharmacy conference experience. This free Summit was specifically developed for entrepreneurial-minded student pharmacists, independent pharmacy owners and private practice consultants. This summit is…
CMS recently released the 2018 Advance Call Letter for Medicare Part D Programs. Submissions for the Medication Therapy Management (MTM) program are due May 1, 2017. The MTM program is the perfect place to gain experience with and understand the…
A recent study in the March 2017 edition of the Journal of Patient Safety (http://insights.ovid.com/crossref?an=01209203-900000000-99520) highlights the extent to which avoidable medication errors impact early readmissions. In this study, the authors evaluated a random sample of 534 potentially avoidable 30-day…